IDH1 and central nervous system cancer: For example, IDH1.R132H and IDH2.R172H mutations have been frequently reported in glioma cases 8, and patients harboring IDH1 and IDH2 mutations have a different metabolic pattern9 and usually have a better prognosis compared to patients with IDH1/2 wild type 10, 11.